Profil
Dr. Line Hartvig has spent more than ten years in the biotech and pharmaceutical industry.
She has a broad understanding of many phases in research and development of pharmaceuticals (small molecules, peptides and biopharmaceuticals).
She has been involved in the creation of new pipeline opportunities (proposal of new projects), compliance to tight project plans and goals, and filling of documentation to regulatory authorities.
Moreover she has experience in transfer of technologies to contract research organisations.
She has worked on numerous projects covering several molecular targets (e.g.
ligand/voltage-gated ion channels, gap junctions, G-protein coupled receptors, coagulation factors) in the fields of neuroscience, cardiology and haemostasis.
She holds a Master of Science degree in Biochemistry from University of Copenhagen and a PhD in molecular and cellular biology from University of Copenhagen and she speaks fluent Danish and English.
Anciens postes connus de Line Hartvig
| Sociétés | Poste | Fin |
|---|---|---|
Sunstone Capital A/S
Sunstone Capital A/S Investment ManagersFinance Sunstone is an active manager which provides equity funding for early-stage capital requirements, and provides management support. The firm targets companies operating in the technology and life sciences sector, and industries such as biotechnology, pharmaceuticals, and information technology services. Sunstone invests in companies located in Denmark and Northern Europe, and looks to take minority stake positions in its investments, as well as a seat on the board. | Analyste en capital-investissement | 01/01/2010 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Sunstone Capital A/S
Sunstone Capital A/S Investment ManagersFinance Sunstone is an active manager which provides equity funding for early-stage capital requirements, and provides management support. The firm targets companies operating in the technology and life sciences sector, and industries such as biotechnology, pharmaceuticals, and information technology services. Sunstone invests in companies located in Denmark and Northern Europe, and looks to take minority stake positions in its investments, as well as a seat on the board. | Finance |
















